세계의 연속 혈당 모니터링 기기 시장 규모 조사 및 예측, 컴포넌트별(센서, 트랜스미터 리시버), 커넥티비티별(Bluetooth, 4G), 최종 사용자별(병원, 홈 케어, 기타), 지역 분석(2022-2029년)

Global Continuous Glucose Monitoring Devices Market is valued approximately USD 7480.19 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2022-2029. Continuous glucose monitoring (CGM) devices are medical devices that are used to monitor the glucose levels in a person's body continuously and in real-time. These devices are typically used by people with diabetes to manage their blood sugar levels. The major driving factors for the Global Continuous Glucose Monitoring Devices Market are increasing incidence of diabetes and growing Geriatric Population. Moreover, rising technological advancement and rising initiatives by the key market players is creating lucrative growth opportunity for the market over the forecast period 2022-2029.

In addition to high blood pressure and high cholesterol, prominent risk factors for diabetes complications include smoking, obesity, inactivity, and being overweight. According to the International Diabetes Federation, there were approximately 536.6 million cases of diabetes worldwide in 2021; this number is projected to rise to 642.8 million by 2030 and 783.7 million by 2045. However, the high cost of Continuous Glucose Monitoring Devices stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Continuous Glucose Monitoring Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the largest market for CGM devices due to the high prevalence of diabetes in this region. The US is the largest market in North America due to the high adoption rate of CGM devices and the presence of key players in the region. Asia-Pacific is the fastest-growing market for CGM devices due to the increasing prevalence of diabetes in this region. The major markets in Asia-Pacific are China, Japan, India, and South Korea.

Major market players included in this report are:

• F. Hoffmann-La Roche Ltd.
• Dexcom Inc.
• Abbott Laboratories
• Medtronic Inc.
• Ypsomed AG
• GlySens Incorporated
• Ascensia Diabetes Care
• Dexcom
• Abbott
• Senseonics

Recent Developments in the Market:

• In June 2022, The EVERSENSE E3 continuous glucose monitoring system has been given a CE mark for usage in the European Union, according to a statement from Ascensia Diabetes Care.

Global Continuous Glucose Monitoring Devices Market Report Scope:

• Historical Data: 2019-2020-2021
• Base Year for Estimation: 2021
• Forecast period: 2022-2029
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Component, Connectivity, End-use, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Component offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Component:

• Sensors
• Transmitters
• Receivers

By Connectivity:

• Bluetooth
• 4G

By End-use:

• Hospitals
• Home Care
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
  • 1.2.1. Continuous Glucose Monitoring Devices Market, by Region, 2019-2029 (USD Million)
  • 1.2.2. Continuous Glucose Monitoring Devices Market, by Component, 2019-2029 (USD Million)
  • 1.2.3. Continuous Glucose Monitoring Devices Market, by Connectivity, 2019-2029 (USD Million)
  • 1.2.4. Continuous Glucose Monitoring Devices Market, by End-use, 2019-2029 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Continuous Glucose Monitoring Devices Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Continuous Glucose Monitoring Devices Market Dynamics

• 3.1. Continuous Glucose Monitoring Devices Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of diabetes
    • 3.1.1.2. Growing Geriatric Population
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Continuous Glucose Monitoring Devices
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Advancements in the product
    • 3.1.3.2. Rising initiatives by key market players

Chapter 4. Global Continuous Glucose Monitoring Devices Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Continuous Glucose Monitoring Devices Market, by Component

• 6.1. Market Snapshot
• 6.2. Global Continuous Glucose Monitoring Devices Market by Component, Performance - Potential Analysis
• 6.3. Global Continuous Glucose Monitoring Devices Market Estimates & Forecasts by Component 2019-2029 (USD Million)
• 6.4. Continuous Glucose Monitoring Devices Market, Sub Segment Analysis
  • 6.4.1. Sensors
  • 6.4.2. Transmitters
  • 6.4.3. Receivers

Chapter 7. Global Continuous Glucose Monitoring Devices Market, by Connectivity

• 7.1. Market Snapshot
• 7.2. Global Continuous Glucose Monitoring Devices Market by Connectivity, Performance - Potential Analysis
• 7.3. Global Continuous Glucose Monitoring Devices Market Estimates & Forecasts by Connectivity 2019-2029 (USD Million)
• 7.4. Continuous Glucose Monitoring Devices Market, Sub Segment Analysis
  • 7.4.1. Bluetooth
  • 7.4.2. 4G

Chapter 8. Global Continuous Glucose Monitoring Devices Market, by End-use

• 8.1. Market Snapshot
• 8.2. Global Continuous Glucose Monitoring Devices Market by End-use, Performance - Potential Analysis
• 8.3. Global Continuous Glucose Monitoring Devices Market Estimates & Forecasts by End-use 2019-2029 (USD Million)
• 8.4. Continuous Glucose Monitoring Devices Market, Sub Segment Analysis
  • 8.4.1. Hospitals
  • 8.4.2. Home Care
  • 8.4.3. Others

Chapter 9. Global Continuous Glucose Monitoring Devices Market, Regional Analysis

• 9.1. Continuous Glucose Monitoring Devices Market, Regional Market Snapshot
• 9.2. North America Continuous Glucose Monitoring Devices Market
  • 9.2.1. U.S. Continuous Glucose Monitoring Devices Market
    • 9.2.1.1. Component breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Connectivity breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End-use breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Continuous Glucose Monitoring Devices Market
• 9.3. Europe Continuous Glucose Monitoring Devices Market Snapshot
  • 9.3.1. U.K. Continuous Glucose Monitoring Devices Market
  • 9.3.2. Germany Continuous Glucose Monitoring Devices Market
  • 9.3.3. France Continuous Glucose Monitoring Devices Market
  • 9.3.4. Spain Continuous Glucose Monitoring Devices Market
  • 9.3.5. Italy Continuous Glucose Monitoring Devices Market
  • 9.3.6. Rest of Europe Continuous Glucose Monitoring Devices Market
• 9.4. Asia-Pacific Continuous Glucose Monitoring Devices Market Snapshot
  • 9.4.1. China Continuous Glucose Monitoring Devices Market
  • 9.4.2. India Continuous Glucose Monitoring Devices Market
  • 9.4.3. Japan Continuous Glucose Monitoring Devices Market
  • 9.4.4. Australia Continuous Glucose Monitoring Devices Market
  • 9.4.5. South Korea Continuous Glucose Monitoring Devices Market
  • 9.4.6. Rest of Asia Pacific Continuous Glucose Monitoring Devices Market
• 9.5. Latin America Continuous Glucose Monitoring Devices Market Snapshot
  • 9.5.1. Brazil Continuous Glucose Monitoring Devices Market
  • 9.5.2. Mexico Continuous Glucose Monitoring Devices Market
• 9.6. Rest of The World Continuous Glucose Monitoring Devices Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. F. Hoffmann-La Roche Ltd.
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Dexcom Inc.
  • 10.2.3. Abbott Laboratories
  • 10.2.4. Medtronic Inc.
  • 10.2.5. Ypsomed AG
  • 10.2.6. GlySens Incorporated
  • 10.2.7. Ascensia Diabetes Care
  • 10.2.8. Dexcom
  • 10.2.9. Abbott
  • 10.2.10. Senseonics

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption